BMJ 2000;320:479-482 ( 19 February )

Papers

Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study

Peretz Lavie, professor a Paula Herer, statistician a Victor Hoffstein, professor of medicine b

a Sleep Laboratory, Bruce Rappaport Faculty of Medicine, Israel Institute of Technology, Haifa, Israel, b Division of Respiratory Medicine, St Michael's Hospital, University of Toronto, Ontario, Canada

Correspondence to: P Lavie plavie{at}techunix.technion.ac.il

    Abstract
Top
Abstract
Introduction
Methods
Results
Discussion
References

Objective: To assess whether sleep apnoea syndrome is an independent risk factor for hypertension.
Design: Population study.
Setting: Sleep clinic in Toronto.
Participants: 2677 adults, aged 20-85 years, referred to the sleep clinic with suspected sleep apnoea syndrome.
Outcome measures: Medical history, demographic data, morning and evening blood pressure, and whole night polysomnography.
Results: Blood pressure and number of patients with hypertension increased linearly with severity of sleep apnoea, as shown by the apnoea-hypopnoea index. Multiple regression analysis of blood pressure levels of all patients not taking antihypertensives showed that apnoea was a significant predictor of both systolic and diastolic blood pressure after adjustment for age, body mass index, and sex. Multiple logistic regression showed that each additional apnoeic event per hour of sleep increased the odds of hypertension by about 1%, whereas each 10% decrease in nocturnal oxygen saturation increased the odds by 13%.
Conclusion: Sleep apnoea syndrome is profoundly associated with hypertension independent of all relevant risk factors.

    Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References

The strong association between obstructive sleep apnoea syndrome and hypertension has attracted considerable attention in recent years.1-6 Despite the accumulated evidence suggesting a causal relation between these two conditions, doubts have been raised about how much of this association is contributed by confounding variables, most notably obesity, age, and male sex. This argument diminished the importance of the syndrome as a major public health problem.7 Differentiating the contribution of confounding factors from that of the repeated apnoeic events and hypoxaemia requires large populations. In an unselected population of state employees, sleep related breathing disorders were a risk factor for hypertension, which was independent of age, body mass index, and sex.6 However, because the population was a sample of the general population rather than of patients with suspected sleep disorders, less than 4% of that population had moderate or severe sleep apnoea.6

No large scale investigations have examined the relation between blood pressure, severity of apnoea, and various confounding factors in patients attending sleep clinics. These patients generally present with more severe forms of sleep related breathing disorders and more confounding variables than the general population, and therefore may be expected to show a different relation between apnoeic events and blood pressure. We investigated these relations in a large population of patients with sleep disorders attending a clinic.

    Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References

Participants
We examined prospectively 2677 adults (aged 20-85 years) referred to the St Michael's Hospital sleep clinic with suspected sleep apnoea. All were both non-selected and consecutively referred for diagnostic sleep recordings over a 10 year period.

Protocol
Nocturnal polysomnography was performed in hospital. This included monitoring of both respiration, with inductance plethysmography and oronasal temperature as substitute measurements of respiratory effort and flow, and oxygen saturation. From these measures we obtained the apnoea-hypopnoea index (total number of apnoeic events plus hypopnoeic events divided by hours of sleep) and the lowest and mean nocturnal oxygen saturation; we also recorded the percentage of time spent asleep with oxygen saturation below 90%. Apnoea was defined as a cessation in airflow of at least 10 seconds, and hypopnoea was defined as a decrease in the amplitude of the respiratory signal of at least 50% for a minimum of 10 seconds followed by either a decrease in oxygen saturation of 4% or signs of physiological arousal.

Anthropometric measurements---We measured the patients' height and weight and neck, hip, and waist circumference, and we calculated their body mass index and waist to hip ratio.

Smoking status was defined as never, present, or past smoker, and pack years of smoking.

Blood pressure measurements were taken six times under standard conditions, with the patients awake and supine, either just before turning off the lights (evening measurements) or just before getting out of bed (morning measurements). Our analysis deals only with mean morning blood pressure readings. Repeating the analysis with the evening values provided similar results.

Hypertension
Hypertension was defined as taking antihypertensives without regard to the actual measurement of blood pressure, or having a systolic blood pressure reading greater than 140 mm Hg or a diastolic blood pressure reading greater than 90 mm Hg. The same definition was used in a study of hypertension in sleep apnoea based on a random sample of the population.6

Statistical analysis
We analysed the association between sleep apnoea and blood pressure with univariate analysis, without any adjustment for confounding variables. Linear trends were verified using the Cochran-Armitage trend test8 for linearity for categorical data, and regression lines for parametric data. We used multiple linear regression to identify the variables that made an important contribution to the variability of blood pressure and to adjust for confounding variables with analysis of covariance. Finally, we used multiple logistic regression modelling to determine the odds ratios of having hypertension associated with an increase in the apnoea-hypopnoea index and a decrease in oxygen saturation. Statistical analysis was performed using SAS software.

    Results
Top
Abstract
Introduction
Methods
Results
Discussion
References

Univariate analysis
Table 1 summarises the characteristics of the patient population of 1949 men and 728 women. Our patients were obese, middle aged males with mild to moderate sleep apnoea, and there was wide scatter in all variables.


                              
View this table:
[in this window]
[in a new window]
 

Table 1. Anthropometric, sleep, and blood pressure data in 2677 adults attending sleep clinic

To show how blood pressure levels vary with apnoea we divided our population into four groups: non-apnoeic controls (apnoea-hypopnoea index 10 or less), mild apnoea (greater than 10 and less than 31), moderate apnoea (greater than 30 and less than 51), and severe apnoea (greater than 50). Table 2 shows that unadjusted systolic and diastolic blood pressures increased with the apnoea-hypopnoea index. Trend analysis, however, showed that the important confounding factors, such as percentage of males, age, obesity (as reflected by body mass index, neck circumference, and waist to hip ratio), and smoking history also significantly increased with the apnoea-hypopnoea index (all P<0.0001).


                              
View this table:
[in this window]
[in a new window]
 

Table 2. Changes in blood pressure and other confounding factors with severity of apnoea. Values are mean (SD) unless stated otherwise

We used the Cochran-Armitage trend test8 to test for linearity in percentage of males, hypertension, and antihypertensive use.


                              
View this table:
[in this window]
[in a new window]
 

Table 3. Multiple linear regression models for blood pressure measurements only in patients not taking antihypertensive drugs (n=1865)

Multiple regression analysis---We performed multiple linear regression in 1865 patients not taking antihypertensives (table 3). This showed that the apnoea-hypopnoea index was significantly related to diastolic and systolic blood pressure after adjustment for age and sex. Age and sex were significant covariates, but there was no interaction between the apnoea-hypopnoea index and age or sex. Smoking was only borderline statistically significant for the diastolic blood pressure, and therefore it was not included in further analysis. Stepwise linear regression, with the apnoea-hypopnoea index, age, and sex forced in the model, indicated that neck circumference (over body mass index, waist or hip circumference, and waist to hip ratio) was the most influential body habitus variable. When neck circumference was added to age and sex, the apnoea-hypopnoea index was still significantly related to diastolic and systolic blood pressures (adjusted R2 21.9% and 19.6% respectively). No interaction occurred between neck circumference and the apnoea-hypopnoea index. Under the conditions of the model, the beta  coefficient for the apnoea-hypopnoea index indicates an increase of 0.10 and 0.04 mm Hg in systolic and diastolic blood pressures respectively for each additional apnoeic event per hour of sleep. The model predicts, for example, that the mean (SD) morning blood pressure readings will be 6 (1.2) mm Hg (systolic) and 4.7 (1.0) mm Hg (diastolic) higher for severe sleep related breathing disorders (apnoea-hypopnoea index 60) versus no sleep related breathing disorders. The same results were found when the analysis was repeated with the lowest nocturnal oxygen saturation.

Multiple logistic regression---To evaluate the effect of the apnoea-hypopnoea index, we performed a multiple logistic regression model of sleep related breathing disorders and hypertension with terms for the apnoea-hypopnoea index, sex, age, body mass index, and an interaction for body mass index and apnoea-hypopnoea index. This indicated that an increase in 10 apnoeic events per hour of sleep increased the risk of having hypertension by about 11.0% (beta  coefficient 0.011, table 4 and fig 1). A similar analysis replacing the apnoea-hypopnoea index with oxygen saturation nadir showed that each 10% decrease in saturation nadir increased the risk of having hypertension by about 13% (0.013; table 5 and fig 2). Using percentage of time spent asleep below 90% oxygen saturation instead of nadir did not improve upon these results.

    Discussion
Top
Abstract
Introduction
Methods
Results
Discussion
References

We investigated the relation between the severity of sleep apnoea syndrome and hypertension in 2677 people attending a sleep clinic. Overall, 40% of our population were defined as hypertensive based on either medical history or blood pressure measurements taken immediately after sleep. Our results showed that sleep apnoea significantly contributed to hypertension independent of all relevant confounding variables. Each apnoeic event per hour of sleep added about 1% to the risk of having hypertension. To prove that sleep apnoea has an independent effect on blood pressure we used techniques for adjustment of case mix based on multivariate statistical models to account for several variables that are strong confounders. Since multiple regression models cannot completely remove confounding effects, we confirmed our results by matching patients with sleep apnoea (apnoea-hypopnoea index greater than 10; no use of antihypertensives), for age (within SD 5 years) and body mass index (within SD 2 kg/m2) with controls (apnoea-hypopnoea index 10 or less). The 674 patients with sleep apnoea we successfully matched (data not shown) had significantly higher blood pressure measurements than their matched controls (122.4 (SD 15.7) versus 118.7 (15.5) mm Hg, t=4.67, paired t test P<0.0001; 73.7 (10.2) versus 70.9 (9.9) mm Hg, t=5.20, P<0.0001).


                              
View this table:
[in this window]
[in a new window]
 

Table 4. Odds ratios for apnoea-hypopnoea index, body mass index, sex, age, and hypertension



View larger version (17K):
[in this window]
[in a new window]
 
Fig 1.   Odds ratios and Wald 95% confidence intervals for hypertension associated with apnoea-hypopnoea index level of 5, 15, 30, 40, 50, 60, and 70 predicted by best fitting multiple logistic model: T=e.012apnoea-hypopnoea index+.081age+.161male+.067body mass index (n=2452)


                              
View this table:
[in this window]
[in a new window]
 

Table 5. Odds ratios for nadir in nocturnal oxygenation, body mass index, sex, age, and hypertension



View larger version (17K):
[in this window]
[in a new window]
 
Fig 2.   Odds ratios and Wald 95% confidence intervals for hypertension associated with oxygen saturation nadir levels of 90%, 80%, 70%, 60%, 50%, and 40% predicted by model hypertension=e-.0133nadir+.081age+.265male+.072body mass index (n=2451)

Our 1% estimate of risk for hypertension for each event per hour of sleep is lower than the 4% previously reported.6 This may be because our reference group comprised a large number of heavy snorers who were suspected of having sleep apnoea but who were found to have an apnoea-hypopnoea index lower than 10. Snoring was previously reported to be associated with increased levels of blood pressure.9

Active approach in diagnosis
Our findings, together with previous reports, 5 6 show that sleep apnoea constitutes an independent risk factor for hypertension. Multivariate analysis of mortality data in patients with sleep apnoea showed that hypertension was a significant independent predictor of cardiopulmonary deaths in these patients.10 These findings have clinical implications concerning diagnosis and treatment of sleep apnoea. Currently, most patients are referred for diagnosis only when symptoms are severe enough to affect their quality of life or to attract the attention of family members. Snorers, even with obvious daytime sleepiness, were reported to be passive in seeking medical help for their symptoms.11 The association of sleep apnoea with hypertension warrants a more active approach in the diagnosis of sleep apnoea.


What is already known on this topic

Previous studies have suggested that sleep apnoea syndrome is associated with hypertension, but until now evidence from a large population attending a sleep clinic in which confounders were controlled for has been lacking

What this paper adds

Based on either medical history or actual blood pressure measurements there is an association between sleep apnoea and hypertension, which is independent of the most important confounders

Sleep apnoea syndrome should be taken into account in the differential diagnosis of essential hypertension



    Acknowledgments

We thank Ms Gay Natanzon for editing and checking the manuscript.

Contributors: PL designed the data analysis and wrote the paper. VH was responsible for data collection and organising the database and participated in writing the paper. PH performed the statistical analysis.

    Footnotes

Funding: Technion Sleep Disorders Center (SDC).

Competing interests: None declared.

    References
Top
Abstract
Introduction
Methods
Results
Discussion
References

1. Hoffstein V, Chan CK, Slutsky AS. Sleep apnea and systemic hypertension: a causal association review. Am J Med 1991; 91: 190-196[CrossRef][Medline].
2. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theories. Am J Med 1995; 98: 118-128[CrossRef][Medline].
3. Millman RP, Redline S, Carlisle CC, Assaf AR, Levinson PD. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest 1991; 99: 861-886[Abstract/Free Full Text].
4. Silverberg DR, Oksenberg A, Radwan H, Iaina A. Sleep related breathing disorders are common distributing factors to the production of essential hypertension but are neglected, underdiagnosed and undertreated. Am J Hypertens 1997; 10: 1319-1325[Medline].
5. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension. A population-based study. Ann Intern Med 1994; 120: 382-388[Abstract/Free Full Text].
6. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746-1752[Abstract].
7. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ 1997; 314: 851-860[Abstract/Free Full Text].
8. Fleiss L. Statistical methods for rates and proportions 2nd ed. New York: Wiley, 1981.
9. Young T, Finn L, Hla KM, Morgan B, Palta M. Snoring as part of a dose-response relationship between sleep-disordered breathing and blood pressure. Sleep 1996; 19: 202-25S.
10. Lavie P, Herer P, Peled R, Berger I, Yoffe N, Zomer J, et al. Mortality in sleep apnea patients---a multivariate analysis of risk factors. Sleep 1995; 18: 149-157[Medline].
11. Martikainen K, Pertinen M, Urponen H, Vuori I, Laippala P, Hasa J. Natural evolution of snoring: a 5-year follow-up study. Acta Neurol Scand 1994; 90: 437-442[Medline].

(Accepted 2 December 1999)


© BMJ 2000

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Sleep apnoea and hypertension
Mark Harrison, Caroline Jones, Elinor Brabin, Peretz Lavie, Donald Silverberg, Arie Oksenberg, and Adrian Iaina
BMJ 2000 321: 237. [Extract] [Full Text]

Sleep apnoea contributes to hypertension
BMJ 2000 320: 0. [Full Text]

This article has been cited by other articles:

  • Serebrovskaya, T. V., Manukhina, E. B., Smith, M. L., Downey, H. F., Mallet, R. T. (2008). Intermittent Hypoxia: Cause of or Therapy for Systemic Hypertension?. Exp. Biol. Med. 233: 627-650 [Abstract] [Full text]  
  • Sorajja, D., Gami, A. S., Somers, V. K., Behrenbeck, T. R., Garcia-Touchard, A., Lopez-Jimenez, F. (2008). Independent Association Between Obstructive Sleep Apnea and Subclinical Coronary Artery Disease. Chest 133: 927-933 [Abstract] [Full text]  
  • Sanders, M. H., Montserrat, J. M., Farre, R., Givelber, R. J. (2008). Positive Pressure Therapy: A Perspective on Evidence-based Outcomes and Methods of Application. Proc Am Thorac Soc 5: 161-172 [Abstract] [Full text]  
  • Amit Benjamin, J, Lewis, K E (2008). Sleep-disordered breathing and cardiovascular disease. Postgrad. Med. J. 84: 15-22 [Abstract] [Full text]  
  • Goncalves, S. C., Martinez, D., Gus, M., de Abreu-Silva, E. O., Bertoluci, C., Dutra, I., Branchi, T., Moreira, L. B., Fuchs, S. C., de Oliveira, A. C. T., Fuchs, F. D. (2007). Obstructive Sleep Apnea and Resistant Hypertension: A Case-Control Study. Chest 132: 1858-1862 [Abstract] [Full text]  
  • Li, J., McGwin, G. Jr, Vaphiades, M. S, Owsley, C. (2007). Non-arteritic anterior ischaemic optic neuropathy and presumed sleep apnoea syndrome screened by the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ). Br. J. Ophthalmol. 91: 1524-1527 [Abstract] [Full text]  
  • Parati, G., Lombardi, C., Narkiewicz, K. (2007). Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293: R1671-R1683 [Abstract] [Full text]  
  • Bucca, C. B., Brussino, L., Battisti, A., Mutani, R., Rolla, G., Mangiardi, L., Cicolin, A. (2007). Diuretics in Obstructive Sleep Apnea With Diastolic Heart Failure. Chest 132: 440-446 [Abstract] [Full text]  
  • Authors/Task Force Members:, , Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A.J., Zanchetti, A., ESC Committee for Practice Guidelines (CPG):, , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., ESH Scientific Council:, , Kjeldsen, S. E., Erdine, S., Narkiewicz, K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Cifkova, R., Dominiczak, A., Fagard, R., Heagerty, A. M., Laurent, S., Lindholm, L. H., Mancia, G., Manolis, A., Nilsson, P. M., Redon, J., Schmieder, R. E., Struijker-Boudier, H. A.J., Viigimaa, M., Document Reviewers:, , Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.-M., Manolis, A. J., Nilsson, P. M., O'Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Viigimaa, M., Waeber, B., Williams, B., Zamorano, J. L. (2007). 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 0: ehm236v1-75 [Full text]  
  • Park, A.-M., Suzuki, Y. J. (2007). Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice. J. Appl. Physiol. 102: 1806-1814 [Abstract] [Full text]  
  • Haentjens, P., Van Meerhaeghe, A., Moscariello, A., De Weerdt, S., Poppe, K., Dupont, A., Velkeniers, B. (2007). The Impact of Continuous Positive Airway Pressure on Blood Pressure in Patients With Obstructive Sleep Apnea Syndrome: Evidence From a Meta-analysis of Placebo-Controlled Randomized Trials. Arch Intern Med 167: 757-764 [Abstract] [Full text]  
  • Itzhaki, S., Dorchin, H., Clark, G., Lavie, L., Lavie, P., Pillar, G. (2007). The Effects of 1-Year Treatment With a Herbst Mandibular Advancement Splint on Obstructive Sleep Apnea, Oxidative Stress, and Endothelial Function. Chest 131: 740-749 [Abstract] [Full text]  
  • Zintzaras, E., Kaditis, A. G. (2007). Sleep-Disordered Breathing and Blood Pressure in Children: A Meta-analysis. Arch Pediatr Adolesc Med 161: 172-178 [Abstract] [Full text]  
  • McNicholas, W. T., Bonsignore, M. R., the Management Committee of EU COST ACTION B26, (2007). Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29: 156-178 [Abstract] [Full text]  
  • Hui, D S, To, K W, Ko, F W, Fok, J P, Chan, M C, Ngai, J C, Tung, A H, Ho, C W, Tong, M W, Szeto, C-C, Yu, C-M (2006). Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax 61: 1083-1090 [Abstract] [Full text]  
  • Coruzzi, P., Gualerzi, M., Bernkopf, E., Brambilla, L., Brambilla, V., Broia, V., Lombardi, C., Parati, G. (2006). Autonomic Cardiac Modulation in Obstructive Sleep Apnea: Effect of an Oral Jaw-Positioning Appliance.. Chest 130: 1362-1368 [Abstract] [Full text]  
  • Tarasiuk, A., Greenberg-Dotan, S., Simon, T., Tal, A., Oksenberg, A., Reuveni, H. (2006). Low socioeconomic status is a risk factor for cardiovascular disease among adult obstructive sleep apnea syndrome patients requiring treatment.. Chest 130: 766-773 [Abstract] [Full text]  
  • Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L. (2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Circulation 113: e873-e923 [Abstract] [Full text]  
  • Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L. (2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Stroke 37: 1583-1633 [Abstract] [Full text]  
  • Norman, D., Loredo, J. S., Nelesen, R. A., Ancoli-Israel, S., Mills, P. J., Ziegler, M. G., Dimsdale, J. E. (2006). Effects of Continuous Positive Airway Pressure Versus Supplemental Oxygen on 24-Hour Ambulatory Blood Pressure. Hypertension 47: 840-845 [Abstract] [Full text]  
  • Hedner, J., Bengtsson-Bostrom, K., Peker, Y., Grote, L., Rastam, L., Lindblad, U. (2006). Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study.. Eur Respir J 27: 564-570 [Abstract] [Full text]  
  • Yinon, D., Lowenstein, L., Suraya, S., Beloosesky, R., Zmora, O., Malhotra, A., Pillar, G. (2006). Pre-eclampsia is associated with sleep-disordered breathing and endothelial dysfunction. Eur Respir J 27: 328-333 [Abstract] [Full text]  
  • McCrae, C. S., Ingmundson, P. T. (2006). Using Graduated in Vivo Exposure to Treat a Claustrophobic Response to Nasal Continuous Positive Airway Pressure: Hispanic Male Veteran Associates Nasal Mask With Gas Masks Worn During Combat. Clinical Case Studies 5: 71-82 [Abstract]  
  • White, D. P. (2006). Sleep apnea.. Proc Am Thorac Soc 3: 124-128 [Abstract] [Full text]  
  • Cooper, V. L, Pearson, S. B, Bowker, C. M, Elliott, M. W, Hainsworth, R (2005). Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia - a mechanism for promoting hypertension in obstructive sleep apnoea. J. Physiol. 568: 677-687 [Abstract] [Full text]  
  • Cormican, L J, Williams, A (2005). Sleep disordered breathing and its treatment in congestive heart failure. Heart 91: 1265-1270 [Abstract] [Full text]  
  • Chen, L., Einbinder, E., Zhang, Q., Hasday, J., Balke, C. W., Scharf, S. M. (2005). Oxidative Stress and Left Ventricular Function with Chronic Intermittent Hypoxia in Rats. Am. J. Respir. Crit. Care Med. 172: 915-920 [Abstract] [Full text]  
  • DYUGOVSKAYA, L., LAVIE, P., LAVIE, L. (2005). Lymphocyte Activation as a Possible Measure of Atherosclerotic Risk in Patients with Sleep Apnea. Ann. N. Y. Acad. Sci. 1051: 340-350 [Abstract] [Full text]  
  • Dyugovskaya, L., Lavie, P., Hirsh, M., Lavie, L. (2005). Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 25: 820-828 [Abstract] [Full text]  
  • Yamauchi, M., Nakano, H., Maekawa, J., Okamoto, Y., Ohnishi, Y., Suzuki, T., Kimura, H. (2005). Oxidative Stress in Obstructive Sleep Apnea. Chest 127: 1674-1679 [Abstract] [Full text]  
  • Lavie, P., Lavie, L., Herer, P. (2005). All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 25: 514-520 [Abstract] [Full text]  
  • Gordon, P, Sanders, M H (2005). Sleep {middle dot} 7: Positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome. Thorax 60: 68-75 [Abstract] [Full text]  
  • Robinson, G V, Stradling, J R, Davies, R J O (2004). Sleep {middle dot} 6: Obstructive sleep apnoea/hypopnoea syndrome and hypertension. Thorax 59: 1089-1094 [Abstract] [Full text]  
  • Cooper, V. L., Bowker, C. M., Pearson, S. B., Elliott, M. W., Hainsworth, R. (2004). Effects of simulated obstructive sleep apnoea on the human carotid baroreceptor-vascular resistance reflex. J. Physiol. 557: 1055-1065 [Abstract] [Full text]  
  • Gagnadoux, F., Nguyen, X.L., Rakotonanahary, D., Vidal, S., Fleury, B. (2004). Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients. Eur Respir J 23: 891-895 [Abstract] [Full text]  
  • Hui, D. S., Ko, F. W., Fok, J. P., Chan, M. C., Li, T. S., Tomlinson, B., Cheng, G. (2004). The Effects of Nasal Continuous Positive Airway Pressure on Platelet Activation in Obstructive Sleep Apnea Syndrome. Chest 125: 1768-1775 [Abstract] [Full text]  
  • Udwadia, Z. F., Doshi, A. V., Lonkar, S. G., Singh, C. I. (2004). Prevalence of Sleep-disordered Breathing and Sleep Apnea in Middle-aged Urban Indian Men. Am. J. Respir. Crit. Care Med. 169: 168-173 [Abstract] [Full text]  
  • Hayashi, M., Fujimoto, K., Urushibata, K., Uchikawa, S.-i., Imamura, H., Kubo, K. (2003). Nocturnal Oxygen Desaturation Correlates With the Severity of Coronary Atherosclerosis in Coronary Artery Disease. Chest 124: 936-941 [Abstract] [Full text]  
  • Cloward, T. V., Walker, J. M., Farney, R. J., Anderson, J. L. (2003). Left Ventricular Hypertrophy Is a Common Echocardiographic Abnormality in Severe Obstructive Sleep Apnea and Reverses With Nasal Continuous Positive Airway Pressure. Chest 124: 594-601 [Abstract] [Full text]  
  • Dyugovskaya, L., Lavie, P., Lavie, L. (2003). Phenotypic and Functional Characterization of Blood {gamma}{delta} T Cells in Sleep Apnea. Am. J. Respir. Crit. Care Med. 168: 242-249 [Abstract] [Full text]  
  • Lattimore, J. o-D. L., Celermajer, D. S., Wilcox, I. (2003). Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 41: 1429-1437 [Abstract] [Full text]  
  • Becker, H. F., Jerrentrup, A., Ploch, T., Grote, L., Penzel, T., Sullivan, C. E., Peter, J. H. (2003). Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea. Circulation 107: 68-73 [Abstract] [Full text]  
  • Dart, R. A., Gregoire, J. R., Gutterman, D. D., Woolf, S. H. (2003). The Association of Hypertension and Secondary Cardiovascular Disease With Sleep-Disordered Breathing. Chest 123: 244-260 [Abstract] [Full text]  
  • W.T. McNicholas and J. Krieger on behalf of the Ta, , Members of the Task Force: W.T. McNicholas , P. Le, (2002). Public health and medicolegal implications of sleep apnoea. Eur Respir J 20: 1594-1609 [Full text]  
  • Malhotra, A., Huang, Y., Fogel, R. B., Pillar, G., Edwards, J. K., Kikinis, R., Loring, S. H., White, D. P. (2002). The Male Predisposition to Pharyngeal Collapse: Importance of Airway Length. Am. J. Respir. Crit. Care Med. 166: 1388-1395 [Abstract] [Full text]  
  • Laaban, J.-P., Pascal-Sebaoun, S., Bloch, E., Orvoen-Frija, E., Oppert, J.-M., Huchon, G. (2002). Left Ventricular Systolic Dysfunction in Patients With Obstructive Sleep Apnea Syndrome. Chest 122: 1133-1138 [Abstract] [Full text]  
  • Siyam, M. A., Benhamou, D. (2002). Difficult Endotracheal Intubation in Patients with Sleep Apnea Syndrome. Anesth. Analg. 95: 1098-1102 [Abstract] [Full text]  
  • Hui, D. S.C., Choy, D. K.L., Wong, L. K.S., Ko, F. W.S., Li, T. S.T., Woo, J., Kay, R. (2002). Prevalence of Sleep-Disordered Breathing and Continuous Positive Airway Pressure Compliance* : Results in Chinese Patients With First-Ever Ischemic Stroke. Chest 122: 852-860 [Abstract] [Full text]  
  • Planes, C., Leroy, M., Fayet, G., Aegerter, P., Foucher, A., Raffestin, B. (2002). Exacerbation of sleep-apnoea related nocturnal blood-pressure fluctuations in hypertensive subjects. Eur Respir J 20: 151-157 [Abstract] [Full text]  
  • Luboshitzky, R., Aviv, A., Hefetz, A., Herer, P., Shen-Orr, Z., Lavie, L., Lavie, P. (2002). Decreased Pituitary-Gonadal Secretion in Men with Obstructive Sleep Apnea. J. Clin. Endocrinol. Metab. 87: 3394-3398 [Abstract] [Full text]  
  • Sjostrom, C, Lindberg, E, Elmasry, A, Hagg, A, Svardsudd, K, Janson, C (2002). Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax 57: 602-607 [Abstract] [Full text]  
  • Young, T., Peppard, P. E., Gottlieb, D. J. (2002). Epidemiology of Obstructive Sleep Apnea: A Population Health Perspective. Am. J. Respir. Crit. Care Med. 165: 1217-1239 [Abstract] [Full text]  
  • DYUGOVSKAYA, L., LAVIE, P., LAVIE, L. (2002). Increased Adhesion Molecules Expression and Production of Reactive Oxygen Species in Leukocytes of Sleep Apnea Patients. Am. J. Respir. Crit. Care Med. 165: 934-939 [Abstract] [Full text]  
  • IP, M. S. M., LAM, B., NG, M. M. T., LAM, W. K., TSANG, K. W. T., LAM, K. S. L. (2002). Obstructive Sleep Apnea Is Independently Associated with Insulin Resistance. Am. J. Respir. Crit. Care Med. 165: 670-676 [Abstract] [Full text]  
  • Fletcher, E. C., Orolinova, N., Bader, M. (2002). Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J. Appl. Physiol. 92: 627-633 [Abstract] [Full text]  
  • Fung, J. W. H., Li, T. S. T., Choy, D. K. L., Yip, G. W. K., Ko, F. W. S., Sanderson, J. E., Hui, D. S. C. (2002). Severe Obstructive Sleep Apnea Is Associated With Left Ventricular Diastolic Dysfunction. Chest 121: 422-429 [Abstract] [Full text]  
  • Smith, R., Ronald, J., Delaive, K., Walld, R., Manfreda, J., Kryger, M. H. (2002). What Are Obstructive Sleep Apnea Patients Being Treated for Prior to This Diagnosis?. Chest 121: 164-172 [Abstract] [Full text]  
  • FOGEL, R. B., MALHOTRA, A., PILLAR, G., EDWARDS, J. K., BEAUREGARD, J., SHEA, S. A., WHITE, D. P. (2001). Genioglossal Activation in Patients with Obstructive Sleep Apnea versus Control Subjects . Mechanisms of Muscle Control. Am. J. Respir. Crit. Care Med. 164: 2025-2030 [Abstract] [Full text]  
  • Parra, O. (2001). Sleep-disordered breathing and stroke: is there a rationale for treatment?. Eur Respir J 18: 619-622 [Full text]  
  • Lavie, L., Perelman, A., Lavie, P. (2001). Plasma Homocysteine Levels in Obstructive Sleep Apnea : Association With Cardiovascular Morbidity. Chest 120: 900-908 [Abstract] [Full text]  
  • Popescu, G, Latham, M, Allgar, V, Elliott, M W (2001). Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use. Thorax 56: 727-733 [Abstract] [Full text]  
  • Stradling, J R, Pepperell, J C T, Davies, R J O (2001). Sleep apnoea and hypertension: proof at last?. Thorax 56: ii45-49 [Full text]  
  • Guilleminault, C., Brooks, S. N. (2001). Excessive daytime sleepiness: A challenge for the practising neurologist. Brain 124: 1482-1491 [Abstract] [Full text]  
  • Hui, D. S. C, Choy, D. K. L., Li, T. S. T., Ko, F. W. S., Wong, K. K., Chan, J. K. W., Lai, C. K. W. (2001). Determinants of Continuous Positive Airway Pressure Compliance in a Group of Chinese Patients With Obstructive Sleep Apnea. Chest 120: 170-176 [Abstract] [Full text]  
  • Fogel, R. B., Malhotra, A., Pillar, G., Pittman, S. D., Dunaif, A., White, D. P. (2001). Increased Prevalence of Obstructive Sleep Apnea Syndrome in Obese Women with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab. 86: 1175-1180 [Abstract] [Full text]  
  • DURAN, J., ESNAOLA, S., RUBIO, R., IZTUETA, A. (2001). Obstructive Sleep Apnea-Hypopnea and Related Clinical Features in a Population-based Sample of Subjects Aged 30 to 70 Yr. Am. J. Respir. Crit. Care Med. 163: 685-689 [Abstract] [Full text]  
  • Shochat, T., Hadas, N., Kerkhofs, M., Herchuelz, A., Penzel, T., Peter, J.H., Lavie, P. (2001). The SleepStripTM: an apnoea screener for the early detection of sleep apnoea syndrome. Eur Respir J 19: 121-126 [Abstract] [Full text]  
  • Hedner, J., Grote, L. (2001). The Link between Sleep Apnea and Cardiovascular Disease . Time to Target the Nonsleepy Sleep Apneics?. Am. J. Respir. Crit. Care Med. 163: 5-6 [Full text]  
  • SHAHAR, E., WHITNEY, C. W., REDLINE, S., LEE, E. T., NEWMAN, A. B., JAVIER NIETO, F., O'CONNOR, G. T., BOLAND, L. L., SCHWARTZ, J. E., SAMET, J. M. (2001). Sleep-disordered Breathing and Cardiovascular Disease . Cross-sectional Results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 163: 19-25 [Abstract] [Full text]  
  • IP, M. S. M., LAM, B., CHAN, L.-Y., ZHENG, L., TSANG, K. W. T., FUNG, P. C. W., LAM, W.-K. (2000). Circulating Nitric Oxide Is Suppressed in Obstructive Sleep Apnea and Is Reversed by Nasal Continuous Positive Airway Pressure. Am. J. Respir. Crit. Care Med. 162: 2166-2171 [Abstract] [Full text]  
  • FLETCHER, E C (2000). Hypertension in patients with sleep apnoea, a combined effect?. Thorax 55: 726-728 [Full text]  
  • Davies, C. W H, Crosby, J. H, Mullins, R. L, Barbour, C., Davies, R. J O, Stradling, J. R (2000). Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 55: 736-740 [Abstract] [Full text]  
  • Harrison, M., Jones, C., Brabin, E., Lavie, P., Silverberg, D., Oksenberg, A., Iaina, A. (2000). Sleep apnoea and hypertension. BMJ 321: 237a-237 [Full text]  
  • (2000). Sleep Apnea: A Risk Factor for Hypertension. JWatch General 2000: 6-6 [Full text]  

Rapid Responses:

Read all Rapid Responses

Not a population study
Kenneth A Locke
bmj.com, 18 Feb 2000 [Full text]
Limited Application to the General Public?
Mark Harrison, et al.
bmj.com, 2 Mar 2000 [Full text]
A Sleep-Clinic Population, Not a Population Study
Peretz Lavie
bmj.com, 6 Mar 2000 [Full text]



Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview